HBF-0079
HBF-0079 is a selective anti-hepatocellular carcinoma agent. HBF-0079 induces cell cycle arrest and Apoptosis. HBF-0079 modulates cell-growth and anti-apoptotic signaling through AKT and mTOR. HBF-0079 exhibits antitumor activity against hepatocellular carcinoma[1].
Product Specifications
CAS Number
315702-93-3
UNSPSC
12352005
Target
Akt; Apoptosis; mTOR
Related Pathways
Apoptosis; PI3K/Akt/mTOR
Field of Research
Cancer
Smiles
C1(C2=CSC(NC3=NC=CC=N3)=N2)=NC=CC=C1
Molecular Formula
C12H9N5S
Molecular Weight
255.30
References & Citations
[1]Cuconati A, et al. Suppression of AKT anti-apoptotic signaling by a novel drug candidate results in growth arrest and apoptosis of hepatocellular carcinoma cells. PLoS One. 2013;8 (1) :e54595.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RC209967L1V 200 µL
RIPK5 (DSTYK) (NM_015375) Human Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details 
sc-352590A 1 g
5- (2,3-dihydro-1,4-benzodioxin-6-yl) -6H-1,3,4-thiadiazin-2-amine
Sign In for Pricing
View Details